These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33009381)

  • 1. Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices.
    Dengl S; Mayer K; Bormann F; Duerr H; Hoffmann E; Nussbaum B; Tischler M; Wagner M; Kuglstatter A; Leibrock L; Buldun C; Georges G; Brinkmann U
    Nat Commun; 2020 Oct; 11(1):4974. PubMed ID: 33009381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatants.
    Paul S; Connor J; Nesspor T; Haytko P; Boakye K; Chiu ML; Jiang H
    Protein Expr Purif; 2016 May; 121():133-40. PubMed ID: 26826313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
    Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
    J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
    Skegro D; Stutz C; Ollier R; Svensson E; Wassmann P; Bourquin F; Monney T; Gn S; Blein S
    J Biol Chem; 2017 Jun; 292(23):9745-9759. PubMed ID: 28450393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.
    Kim HS; Dunshee DR; Yee A; Tong RK; Kim I; Farahi F; Hongo JA; Ernst JA; Sonoda J; Spiess C
    Protein Eng Des Sel; 2017 Sep; 30(9):627-637. PubMed ID: 28985411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of common light chain IgG-like bispecific antibodies using highly linear pH gradients.
    Sharkey B; Pudi S; Wallace Moyer I; Zhong L; Prinz B; Baruah H; Lynaugh H; Kumar S; Wittrup KD; Nett JH
    MAbs; 2017; 9(2):257-268. PubMed ID: 27937066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies.
    Giese G; Williams A; Rodriguez M; Persson J
    Biotechnol Prog; 2018 Mar; 34(2):397-404. PubMed ID: 29193902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties.
    Nyesiga B; Levin M; Säll A; Rosén A; Jansson K; Fritzell S; Hägerbrand K; Weilguny D; von Schantz L
    MAbs; 2024; 16(1):2330113. PubMed ID: 38527972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific antibody target pair discovery by high-throughput phenotypic screening using in vitro combinatorial Fab libraries.
    Bhatta P; Whale KD; Sawtell AK; Thompson CL; Rapecki SE; Cook DA; Twomey BM; Mennecozzi M; Starkie LE; Barry EMC; Peters SJ; Kamal AM; Finney HM
    MAbs; 2021; 13(1):1859049. PubMed ID: 33487120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'In-Format' screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules.
    Scott MJ; Lee JA; Wake MS; Batt KV; Wattam TA; Hiles ID; Batuwangala TD; Ashman CI; Steward M
    MAbs; 2017 Jan; 9(1):85-93. PubMed ID: 27786601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities.
    Li Y
    Protein Expr Purif; 2019 Mar; 155():112-119. PubMed ID: 30513344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies.
    Guo G; Han J; Wang Y; Li Y
    Protein Expr Purif; 2020 Sep; 173():105647. PubMed ID: 32334139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
    Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
    MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig
    Koga H; Kuroi H; Hirano R; Hirayama H; Nabuchi Y; Kuramochi T
    Antibodies (Basel); 2024 Jan; 13(1):. PubMed ID: 38247567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
    Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
    Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of half antibody, hole-hole homodimer and aggregates during bispecific antibody purification using MMC ImpRes mixed-mode chromatography.
    Tang J; Zhang X; Chen T; Wang Y; Li Y
    Protein Expr Purif; 2020 Mar; 167():105529. PubMed ID: 31698035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation.
    Debaene F; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2013 Oct; 85(20):9785-92. PubMed ID: 24007193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General strategies for IgG-like bispecific antibody purification.
    Li Y
    Biotechnol Prog; 2024 Oct; ():e3515. PubMed ID: 39410750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.